Support Alert

Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older

The Commission on Human Medicines has issued a series of recommendations to strengthen measures to minimise risk with the yellow fever vaccine (Stamaril) following very rare fatal reactions..

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society